EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer.
EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer. Cancer Lett. 2022 06 28; 536:215641.